Utility of pharmacogenomic tests in treating pediatric depression, anxiety and ADHD

Despite the scientific advancement and increasing interest in the use of pharmacogenomic tests to determine how genes interact with medications, such tests require nuanced understanding and interpretation in the treatment of pediatric depression, anxiety, and ADHD. Pharmacogenomic testing can be useful in certain populations to identify a psychotropic medication’s tolerability or adverse effects. Pharmacogenomic testing cannot predict which medication will provide the best clinical response in a…

via https://pubmed.ncbi.nlm.nih.gov/42888153/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20261021010904&v=2.20.1